Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St futures slip as chip stocks drag; Netflix tumbles
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Goldman sees central bank demand providing a floor for gold prices
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
Questcor (QCOR) Slammed on U.S. Marketing Probe, Ratings Downgrade on Acthar Risk
September 24, 2012 7:59 AM EDTShares of Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) are getting slammed in early trading Monday, down over 25 percent in pre-market action. The drop is the result of Questcor... More
U.S. Commences Probe into Questcor (QCOR) Over Marketing Practices
September 24, 2012 6:25 AM EDTOn September 21, 2012, Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) became aware of a U.S. government investigation involving the Companys promotional practices.
The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional... More
